Outsourcing

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.

China rises to the top as a destination for international outsourcing.

Insights from real-time ranking of global biomanufacturing capabilities.

Incorporating regulatory requirements into the product life cycle is crucial.

Better strategies and practices in sourcing and procurement can contribute to the bottom line.

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.

Clear documentation and open communication are essential for effective technology transfer.

Rapid microbial screening provided by contract laboratories can save companies time and money.

Addressing supply-chain challenges.

Mergers and acquisitions expected to increase, as big companies bolster piplines by acquiring smaller biotech companies.

New supply-chain challenges are forcing companies to act in different ways to secure product safety.

The authors examine several issues that will help streamline negotiations between a service provider and a cell-culture medium consumer.

The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.

The authors present the CMO's perspective on various potential sources of sponsor-CMO conflicts.

Indian manufacturers are not now a threat to Western CMOs, but may be long term.

Biotech companies will have a much better shot at success with a project management plan and team in place from the very outset

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

Covance's deal with Sanofi-Aventis demonstrates the power of scale and scope.

Venture capital is still scarce for early biotechs and their providers.

How current economic conditions affect your build-or-buy decision.

This month, we catch up on major developments around the world and their implications for the contract services industry.

Apply risk management principles to monitor outsourced activities.

How much to spend on early development, whether to use your CMO's proprietary cell line, and other outsourcing advice.

Being open to unforseen events may avert risk or create opportunities.

Formulation strategy is an important consideration when selecting and managing outsourced biopharmaceutical development programs.

It is important that all stages of the audit be given an equal measure of attention.

A process harmonization assessment can aid in smooth technology transfer by comparing data across equipment and sites.

Insourcing is new outsourcing. Here's how to do it right.

Partner with a contract manufacturing organization that integrates best practices from project management, customer service, and Lean.